EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Frequency of Sexual Dysfunction among Patients Receiving Selective Serotonin Reuptake Inhibitors

Amir Wahab, Israr Ud Din, Sumaira Mehreen

Journal of Gandhara Medical and Dental Science · 30.06.2026 · 13 (3) · 25-28

DOI: 10.37762/jgmds.13-3.858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gandhara Medical and Dental Science, online erschienen am 30.06.2026. Verfasst von Amir Wahab und 2 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES This study aims to determine the frequency of sexual dysfunction among patients undergoing SSRI treatment. METHODOLOGY A cross-sectional study was conducted at the Department of Psychiatry, MTI Lady Reading Hospital, Peshawar, from December 2023 to June 2024. Using non-probability consecutive sampling, 288 patients aged 20-40 years receiving SSRIs for at least 12 weeks for various psychiatric disorders were enrolled. Patients with severe medical illnesses, substance dependence, or pre-existing sexual dysfunction were excluded. Sexual dysfunction was assessed using the Arizona Sexual Experience Scale (ASEX). Data were analyzed using SPSS version 26. Chi-square test was applied, and p≤0.05 was considered statistically significant. RESULTSThe mean age of the patients was 27.20±5.40 years. The mean duration of SSRI use was 2.61±1.12years. The p-value >.05 indicated that there is no statistically significant correlation between SSRI duration (1-3 years vs. >3 years) and sexual dysfunction. Among the participants who had sexual dysfunction, 56 (62.2%) were male, while 34 (37.8%) were female and aged 2-30 years, but the association was not statistically significant (χ² = 1.34, p = 0.246, φ = 0.07). The chi-square result shows no statistically significant difference between demographic and clinical variables and sexual dysfunction, and the effect size shows a very small association. CONCLUSION A substantial proportion of patients receiving SSRIs experienced sexual dysfunction, highlighting the need for routine screening and counseling in psychiatric practice.

Zitieren

APA

Wahab, A., Din, I. U., & Mehreen, S. (2026). Frequency of Sexual Dysfunction among Patients Receiving Selective Serotonin Reuptake Inhibitors. Journal of Gandhara Medical and Dental Science, 13(3), 25-28. https://doi.org/10.37762/jgmds.13-3.858

Vancouver

Wahab A, Din IU, Mehreen S. Frequency of Sexual Dysfunction among Patients Receiving Selective Serotonin Reuptake Inhibitors. Journal of Gandhara Medical and Dental Science. 2026;13(3):25-28. doi:10.37762/jgmds.13-3.858

BibTeX
@article{Wahab2026,
  author = {Wahab, Amir and Din, Israr Ud and Mehreen, Sumaira},
  title = {Frequency of Sexual Dysfunction among Patients Receiving Selective Serotonin Reuptake Inhibitors},
  journal = {Journal of Gandhara Medical and Dental Science},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {25--28},
  doi = {10.37762/jgmds.13-3.858}
}
Kostenlos starten →